Head Injury and Low Testosterone in Clinical Research

Head injury can cause low testosterone, but it happens far less often than studies suggest. At Longevity Benchmark, we evaluate endocrine research to separate verified hormone loss from common testing artifacts. A blow to the head damages growth hormone production more often than it impairs sex steroids.

Headline Prevalence Estimates for Pituitary Damage

Large systematic reviews report widely divergent estimates of post-traumatic hypopituitarism. A 2024 meta-analysis in Neurosurgical Review examined 52 studies covering 7,367 participants with traumatic brain injury (TBI). That paper calculated a pooled prevalence of 33% for any pituitary axis dysfunction, with a 95% confidence interval (CI) of 28 to 37%.

Earlier pooled data produced a comparable estimate for chronic impairment. A 2007 meta-analysis in JAMA reviewed 19 studies of 1,137 patients and calculated chronic-phase hypopituitarism at 27.5%, with a 95% CI of 22.8 to 28.9%. That review noted that hormone deficiencies appeared more frequently after severe trauma than after mild or moderate trauma.

Recent clinical reviews propose a much lower figure. A 2026 Approach to the Patient review in the Journal of Clinical Endocrinology & Metabolism states that the actual prevalence of hypopituitarism after TBI sits at about 15%. This creates an unresolved gap between meta-analytic summaries and current clinical appraisals.

Testing Methodology as the Cause of Disagreement

The wide disagreement among published prevalence figures stems from whether investigators confirm abnormal lab results with a second draw. A 2015 review in Endocrine Reviews observed that reported frequencies range between 15% and 50% across most published literature. That same review pointed out that estimates of persistent hypopituitarism fall to 12% when clinical protocols require repeated testing.

Single blood draws catch transient metabolic fluctuations that resemble structural endocrine damage. In the 2024 Neurosurgical Review meta-analysis, statistical heterogeneity ranged from 53% to 97% across included cohorts. The authors attributed this extreme variance to differing injury severity classifications, disparate study designs, variable diagnostic criteria, and inconsistent timing of hormone evaluations.

Axis Deficits in Head Injury and Low Testosterone

Pituitary tissue damage after trauma impairs growth hormone regulation more frequently than sex steroid production. Data from the 2024 Neurosurgical Review meta-analysis established that growth hormone (GH) deficiency occurs in 18% of patients, with a 95% CI of 14 to 21%. Impairment of the pituitary-gonadal axis, which governs luteinizing hormone (LH) and follicle-stimulating hormone (FSH), followed at 16%, with a 95% CI of 12 to 19%.

Other endocrine axes fail less frequently in pooled evaluations. Deficiencies in adrenocorticotropic hormone (ACTH) appeared in 10% of patients, thyroid-stimulating hormone (TSH) failed in 6%, and multiple axes were compromised in 7%. Growth hormone is the most commonly lost hormone after trauma in these pooled data, with the gonadal axis second and ACTH, multiple axes and TSH below it.

Patients concerned about post-traumatic hypogonadism frequently look for low testosterone first. In the clinical literature, testosterone loss is a secondary consequence of upstream gonadotropin disruption rather than the primary vulnerability. Our guide to the signs of low testosterone covers how these symptoms present in general practice.

Acute Suppression Versus Chronic Endocrine Loss

Blood draws taken within days of a head injury capture temporary physiological stress rather than permanent pituitary failure. In a study published in Clinical Endocrinology by Agha and colleagues, researchers tested 50 consecutive patients with moderate-to-severe TBI at a median of 12 days post-injury. Fully 80% showed gonadotrophin deficiency with low sex steroid levels, which largely reflects acute critical-illness suppression rather than permanent damage.

In that same early cohort, circulating testosterone correlated positively with Glasgow Coma Scale scores (r = 0.32, P = 0.04), indicating that lower initial testosterone tracked with greater injury severity. Over longer periods, many hormonal disruptions resolve spontaneously. A prospective study in the Journal of Clinical Endocrinology & Metabolism by Aimaretti and colleagues retested 70 patients, finding hypopituitarism in 32.8% at 3 months and 22.7% at 12 months.

While panhypopituitarism was always confirmed at 12 months in that study, multiple and isolated deficits were confirmed in only 25%. Furthermore, in 5.5% of patients with normal baseline tests, an isolated deficiency appeared at the one-year mark. In a long-term cohort of 82 patients published in Hormones by Nemes and colleagues, 31.7% experienced significant endocrine changes during follow-up.

New deficiencies developed in 16 patients, and disturbances resolved in 10.

Retired Football Players and Cut-Off Sensitivity

Investigations of retired professional contact-sport athletes highlight how diagnostic cut-offs manipulate reported rates of endocrine failure. A study by Kelly and colleagues in the Journal of Neurotrauma evaluated 68 retired National Football League (NFL) players who reported impaired quality of life. Mean age was 47.3 years and mean body mass index (BMI) was 33.8.

Median time in the league was 5 years, and the median concussion count was 3.

Using a standard glucagon stimulation threshold below 3 nanograms per millilitre, 41.2% of the men met criteria for GH deficiency. When investigators applied a BMI-adjusted cut-off to the same blood samples, the GH deficiency rate dropped to 19.1%. Across the cohort, 23.5% met the adjusted criteria for any hormone deficiency, with isolated hypogonadism identified in 4.4% and combined deficiencies in another 4.4%, leaving total hypogonadism at roughly 9%.

The authors found no correlation between hormone deficiency and career trauma metrics. Player age, BMI, total seasons, games played, concussion count, and past steroid use were similar between deficient and non-deficient groups. The authors concluded that the underlying cause of hormone deficiency in this group remains unclear.

Concussion Symptom Surveys Without Blood Draws

Large observational surveys frequently link concussion histories to testosterone therapy, but these registries rarely collect biological specimens. A 2019 study in JAMA Neurology by Grashow and colleagues surveyed 3,409 former professional football players with a median age of 52.5 years. In that sample, 18.3% reported indicators of low testosterone, while 22.7% reported signs of erectile dysfunction.

Players in the highest quartile of concussion symptoms were compared against those in the lowest. The odds ratio for low testosterone was 2.39, with a 95% CI of 1.79 to 3.19. These statistical associations, however, carry substantial methodological limitations that the authors documented.

Investigators collected no serum samples, relying entirely on self-reported recollections of whether a clinician had ever recommended testosterone medication. Furthermore, concussion symptoms were gathered retrospectively through an unvalidated survey instrument, the overall response rate was only 25.6%, and none of the reported outcomes were verified against medical records.

Hormone Patterns Observed in Combat Sports

Endocrine evaluations in combat sports reinforce the finding that repetitive head impacts target growth hormone rather than testosterone. A study in the Journal of Endocrinological Investigation by Kelestimur and colleagues tested 11 active boxers alongside 7 matched control participants. Mean peak GH following stimulation measured 10.9 micrograms per litre in boxers compared to 41.4 in controls, leaving 45% of the boxers with severe GH deficiency.

Despite marked growth hormone suppression, all other anterior pituitary hormones remained normal in the tested boxers. Similar patterns appeared in amateur kickboxing. A study published in Clinical Endocrinology by Tanriverdi and colleagues evaluated 22 amateur kickboxers, identifying GH deficiency in 22.7% and ACTH deficiency in 9.1%.

In the boxing cohort, all the other pituitary hormones were reported as normal. The kickboxing study reported growth hormone and ACTH deficiency, and no gonadotropin result at all. Repetitive mild head trauma is far better evidenced for growth hormone loss than for gonadotropin loss.

Structural and Vascular Mechanisms of Injury

The exact physiological mechanism linking head trauma to pituitary dysfunction is not entirely clear. An autopsy series recorded haemorrhage and infarction in and around the pituitary and hypothalamus after fatal closed head injury. A prospective study in the Journal of Trauma by Chaturvedi and colleagues examined 34 fatal head injury cases.

Hypothalamic haemorrhages appeared in 65.2% and capsular haemorrhages in 50%. Posterior pituitary haemorrhages were present in 25%, anterior pituitary infarcts in 21.8%, and hypothalamic infarcts in 17.3%.

Anterior pituitary infarcts were present in 10% of patients dying within 24 hours compared to 27.3% of those surviving past that mark, while hypothalamic infarcts appeared solely in late deaths. The authors concluded that secondary insults, delayed vascular and ischaemic processes rather than the impact itself, account for a proportion of these lesions.

Beyond vascular injury, researchers suspect possible autoimmune and genetic contributions. In the European Journal of Endocrinology, Tanriverdi and colleagues studied 61 male amateur boxers. Antipituitary antibodies appeared in 22.9% and antihypothalamus antibodies in 21.3%.

No control participant had either. Hormone dysfunction was significantly more common in antibody-positive boxers (46.2%) than in antibody-negative boxers (10.4%), suggesting an ongoing immune reaction in a subset of athletes.

Diagnostic Blood Panels for Head Injury and Low Testosterone

Distinguishing between primary testicular failure and secondary pituitary impairment requires testing gonadotropins alongside total testosterone. Primary hypogonadism presents with low testosterone paired with elevated LH and FSH concentrations. Secondary hypogonadism displays low testosterone accompanied by low or inappropriately normal LH and FSH levels.

Because post-traumatic endocrine dysfunction follows a secondary pattern, a laboratory draw measuring total testosterone alone cannot identify pituitary damage. The Endocrine Society clinical guideline recommends measuring both LH and FSH to establish whether hypogonadism originates in the testes or the brain. Furthermore, the American Urological Association (AUA) advises measuring serum prolactin whenever low testosterone coincides with low or low-normal LH concentrations.

Standard trauma guidelines outline specific baseline tests and patient criteria. Guidance from the British Neurotrauma Group, published in the Journal of Neurology, Neurosurgery & Psychiatry, sets the baseline panel at a 09:00 draw. For male patients it covers electrolytes, free T4, TSH, cortisol, LH, FSH, testosterone, sex hormone-binding globulin (SHBG), and albumin.

That guidance excludes insulin-like growth factor 1 (IGF-1), prolactin, and dynamic stimulation tests from initial screening, reserving specialist referral for patients with low baseline markers. Our review of the men's hormone panel covers standard laboratory configurations.

Methodological Limits in Post-Traumatic Hormone Studies

Methodological inconsistencies across published trials prevent clinicians from treating historical prevalence rates as fixed benchmarks. A systematic review in the European Journal of Endocrinology by Kokshoorn and colleagues evaluated 14 studies comprising 931 patients at least one year post-TBI. Secondary hypogonadism ranged from 0% to 29%, growth hormone deficiency from 2% to 39%, and adrenal insufficiency from 0% to 60%.

The authors conclude that these differences prohibit simple generalisations.

Diagnostic criteria frequently misclassify healthy individuals as hormonally deficient. A critical analysis in the Journal of Clinical Medicine by Klose and Feldt-Rasmussen argued that published estimates are systematically inflated. Highly sensitive testing thresholds mean that one in four individuals who fail a stimulation cut-off represent false positives, and elevated BMI independently suppresses growth hormone secretion without pituitary pathology.

Our guide to normal versus optimal reference ranges details how population cut-offs shift clinical classifications.

Clinical overlap further complicates accurate identification because hypopituitarism symptoms mirror the chronic neurological sequelae of TBI itself. These studies do not describe men experiencing non-specific fatigue without a documented history of moderate-to-severe trauma or concussive impacts. Consistent BMI-adjusted cut-offs and mandatory confirmatory retesting across prospective trials would substantially clarify true prevalence rates.

Two questions do the most work with an endocrinologist. Which morning markers would show secondary pituitary impairment, and would a confirmatory retest separate that from temporary illness suppression?

Related

• Signs of Low Testosterone
• Men's Hormone Panel Overview
• Free Versus Total Testosterone
• Sex Hormone-Binding Globulin Biomarker Guide
• Normal Versus Optimal Reference Ranges